Targeted treatment of antibiotics and other pharmaceutical residues with Arvia’s Nyex™ treatment process, to support the prevention of Antimicrobial Resistance (AMR): PRESENTATION ONLY

Proceedings

Targeted treatment of antibiotics and other pharmaceutical residues with Arvia’s Nyex™ treatment process, to support the prevention of Antimicrobial Resistance (AMR): PRESENTATION ONLY

Marjan, A. and Jeffrey, R, Arvia Technology Ltd, UK
(free)

What is Antimicrobial Resistance (AMR)?
• AMR is when bacteria and viruses mutate due to the over use of antimicrobial drugs
• It is estimated that by 2050 there will be over 10 million deaths per year caused by AMR
• Antimicrobial resistant microbes have been found in people, animals and in the environment

The Challenges Surrounding AMR
• Excessive and inappropriate use of antibiotics
• Environmental contamination from manufacturing discharges
• A lack of development surrounding the creation of new antibiotics
• The amount of microbes in the environment

Please fill in your details to download the proceedings

Title
First Name	Please enter your first name.
Surname	Please enter your surname.
Email	Please enter a valid email address.
Contact number	Please enter a valid phone number.
Job title
Organisation	Please enter your organisation.
Country	Please enter your country.
Select Your Interests	Wastewater Conference and training Biosolids and Bioresources Conferences & Training Water Supply Conferences & Training Company news and Updates Please choose an interest.
By submitting this form, you agree that we may use the data you provide to contact you with information related to your request/submission and other relevant Aqua Enviro services. You can unsubscribe from Aqua Enviro marketing emails at any time by clicking the unsubscribe link in the email. To learn more, see our Privacy Policy

Proceedings